Biotage AB (publ) (BITGF)
USD 11.5
(31.13%)
USD 11.5
(31.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 42.83 Million USD | 15.61% |
| 2022 | 41.16 Million USD | 8.21% |
| 2021 | 35.56 Million USD | 3.66% |
| 2020 | 33.03 Million USD | 16.31% |
| 2019 | 28.4 Million USD | 32.21% |
| 2018 | 22.5 Million USD | 1.96% |
| 2017 | 20.69 Million USD | 41.57% |
| 2016 | 14.88 Million USD | 11.09% |
| 2015 | 13.41 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 111 Million USD | 861.06% |
| 2024 Q2 | 12.2 Million USD | 2.2% |
| 2024 Q1 | 11.3 Million USD | -42.75% |
| 2023 Q1 | 9.3 Million USD | 35.29% |
| 2023 Q4 | 19.24 Million USD | 80.37% |
| 2023 FY | - USD | 39.84% |
| 2023 Q3 | 10.67 Million USD | 37.63% |
| 2023 Q2 | 7.75 Million USD | -16.65% |
| 2022 Q1 | 12.95 Million USD | 45.28% |
| 2022 Q4 | 6.87 Million USD | -30.94% |
| 2022 Q3 | 9.95 Million USD | -7.07% |
| 2022 FY | - USD | 8.21% |
| 2022 Q2 | 10.71 Million USD | -17.31% |
| 2021 Q4 | 8.91 Million USD | -4.43% |
| 2021 Q2 | 9.7 Million USD | -4.67% |
| 2021 FY | - USD | 3.66% |
| 2021 Q1 | 10.18 Million USD | 0.0% |
| 2021 Q3 | 9.33 Million USD | -3.87% |
| 2020 FY | - USD | 16.31% |
| 2019 FY | - USD | 32.21% |
| 2018 FY | - USD | 1.96% |
| 2017 FY | - USD | 41.57% |
| 2016 FY | - USD | 11.09% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 4544.175% |
| Ansell Limited | 209.86 Million USD | 79.587% |
| Ansell Limited | 206.3 Million USD | 79.234% |
| BG Medicine, Inc. | - USD | -Infinity% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 2736.375% |
| Psykey, Inc. | -1.29 Million USD | 3407.316% |
| ConvaTec Group Plc | 455.5 Million USD | 90.595% |
| ConvaTec Group Plc | 455.5 Million USD | 90.595% |
| Encision Inc. | -544.19 Thousand USD | 7972.142% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 30309.296% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 39070.074% |
| Innovative MedTech Inc. | -7.67 Million USD | 658.259% |
| LifePoint, Inc. | -14.2 Million USD | 401.643% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 792.416% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 13281.478% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 20003.827% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 10657.292% |
| SmileDirectClub, Inc. | -186.13 Million USD | 123.015% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 90.434% |
| SheerVision, Inc. | -110.53 Thousand USD | 38858.178% |
| United Health Products, Inc. | -2.5 Million USD | 1812.076% |
| Vasamed, Inc. | -4.57 Million USD | 1036.503% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 1994.949% |
| Yubo International Biotech Limited | -1.17 Million USD | 3737.625% |